Chemotactic and proangiogenic role of calcium sensing receptor is linked to secretion of multiple cytokines and growth factors in breast cancer MDA-MB-231 cells

• Published in: Biochimica et biophysica acta Vol. 1853; no. 1; pp. 166 - 182
• Main Authors: Hernández-Bedolla, Marco Antonio, Carretero-Ortega, Jorge, Valadez-Sánchez, Margarita, Vázquez-Prado, José, Reyes-Cruz, Guadalupe
• Format: Journal Article
• Language: English
• Published: Netherlands Elsevier B.V 01.01.2015
• Subjects: Angiogenesis; Aniline Compounds - pharmacology; Breast cancer; Breast Neoplasms - immunology; Breast Neoplasms - pathology; Breast Neoplasms - physiopathology; Calcium - metabolism; Calcium sensing receptor; Cell Line, Tumor; Chemokines - secretion; Chemotactic; Chemotaxis - physiology; Cytokines - secretion; Female; G-protein coupled receptor; Humans; Intercellular Signaling Peptides and Proteins - secretion; Interleukin-6 - physiology; Neovascularization, Physiologic - physiology; Phenethylamines; Propylamines; Receptors, Calcium-Sensing - physiology; Secretion; Angiogenesis; Breast cancer; G-protein coupled receptor; Calcium sensing receptor; Secretion; Chemotactic
• ISSN: 0167-4889; 0006-3002; 1879-2596; 1878-2434
• DOI: 10.1016/j.bbamcr.2014.10.011

Breast cancer metastasis to the bone, potentially facilitated by chemotactic and angiogenic cytokines, contributes to a dramatic osteolytic effect associated with this invasive behavior. Based on the intrinsic ability of calcium sensing receptor (CaSR) to control hormonal secretion and considering its expression in the breast, we hypothesized that CaSR plays a chemotactic and proangiogenic role in highly invasive MDA-MB-231 breast cancer cells by promoting secretion of multiple cytokines. In this study, we show that MDA-MB-231 cells stimulated with R-568 calcimimetic and extracellular calcium secreted multiple cytokines and growth factors that induced endothelial cell migration and in vitro angiogenesis. These effects were dependent on the activity of CaSR as demonstrated by the inhibitory effect of either anti-CaSR blocking monoclonal antibodies or calcilytic NPS-2143. Moreover, CaSR knockdown prevented the proangiogenic effect of CaSR agonists. Importantly, CaSR promoted secretion of pleiotropic molecules like GM-CSF, EGF, MDC/CCL22, FGF-4 and IGFBP2, all known to be chemotactic mediators with putative angiogenic factor properties. In contrast, constitutive secretion of IL-6 and β-NGF was attenuated by CaSR. In the case of normal mammary cells, secretion of IL-6 was stimulated by CaSR, whereas a constitutive secretion of RANTES, Angiogenin and Oncostatin M was attenuated by this receptor. Taken together, our results indicate that an altered secretion of chemotactic and proangiogenic cytokines in breast cancer cells is modulated by CaSR, which can be considered a potential target in the therapy of metastatic breast cancer. [Display omitted] •Breast cancer cells secrete chemotactic and angiogenic factors upon CaSR stimulation.•CaSR attenuates constitutive secretion of IL6 by breast cancer cells.•CaSR differentially regulates cytokine secretion of normal and cancerous breast cells.